Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medivolve Inc (MEDV.NE)

Medivolve Inc (MEDV.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 811
  • Shares Outstanding, K 27,019
  • Annual Sales, $ 686 K
  • Annual Income, $ -16,458 K
  • 60-Month Beta 1.99
  • Price/Sales 0.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MEDV.NE with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.45
  • Most Recent Earnings $-0.13 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0150 +100.00%
on 02/22/24
0.0300 unch
on 02/22/24
+0.0050 (+20.00%)
since 01/22/24
3-Month
0.0150 +100.00%
on 02/22/24
0.0300 unch
on 02/22/24
+0.0100 (+50.00%)
since 11/22/23
52-Week
0.0150 +100.00%
on 02/22/24
0.1300 -76.92%
on 03/08/23
-0.0900 (-75.00%)
since 02/22/23

Most Recent Stories

More News
Medivolve Provides Update on its Mobile Clinic Network

TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Announces Results of Annual and Special Shareholder Meeting

TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC), reports, in accordance with...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Announces Q1 2022 Financial Results

Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December 31, 2021.Cash provided by operating activities was...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Announces Launch of Normal Course Issuer Bid

TORONTO, May 03, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce its...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Welcomes Vincent Chen as VP of Corporate Development

TORONTO, April 06, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC) announced today that Vincent...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve to Host Live Webinar to Discuss Corporate Update

TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC) is pleased to announce that...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Announces Q4 2021 Annual Results

The Company has included amended disclosures in its management discussion and analysis (“MD&A”) for the year ended December 31, 2021 to address...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Announces Appointment of Peter Michel as New Chief Financial Officer

TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC) announces the appointment of...

MEDV.NE : 0.0300 (+50.00%)
OTC.VN : 0.325 (+3.17%)
Medivolve Completes Previously Announced Private Placement Financing

Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management.

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Announces Private Placement Financing of up to $12 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities...

See More

Key Turning Points

3rd Resistance Point 0.0500
2nd Resistance Point 0.0400
1st Resistance Point 0.0350
Last Price 0.0300
1st Support Level 0.0200
2nd Support Level 0.0100
3rd Support Level 0.0050

See More

52-Week High 0.1300
Fibonacci 61.8% 0.0861
Fibonacci 50% 0.0725
Fibonacci 38.2% 0.0589
Last Price 0.0300
52-Week Low 0.0150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar